Literature DB >> 7757050

Pertussis in Quebec: ongoing epidemic since the late 1980s.

G De Serres1, N Boulianne, M Douville Fradet, B Duval.   

Abstract

Mesh：

Year:  1995        PMID： 7757050

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN： 1188-4169


× No keyword cloud information.
  21 in total

1.  Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom.

Authors:  N K Fry; S Neal; T G Harrison; E Miller; R Matthews; R C George
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

2.  Economic evaluation of a new acellular vaccine for pertussis in Canada.

Authors:  M Iskedjian; T R Einarson; B J O'Brien; J G De Serres; R Gold; I M Gemmill; N Milkovich; A Rosner
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

3.  Multilocus sequence typing of Bordetella pertussis based on surface protein genes.

Authors:  Inge H M van Loo; Kees J Heuvelman; Audrey J King; Frits R Mooi
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

4.  Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland.

Authors:  F R Mooi; Q He; H van Oirschot; J Mertsola
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

5.  Strain variation among Bordetella pertussis isolates from Québec and Alberta provinces of Canada from 1985 to 1994.

Authors:  Mark S Peppler; Sharee Kuny; Anna Nevesinjac; Christina Rogers; Yvon R de Moissac; Kathleen Knowles; Manon Lorange; Gaston De Serres; James Talbot
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

6.  Economic evaluation of an extended acellular pertussis vaccine program for adolescents in Québec, Canada.

Authors:  Michael Iskedjian; John H Walker; Gaston De Serres; Thomas R Einarson
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

7.  Antigenic divergence between Bordetella pertussis clinical isolates from Moscow, Russia, and vaccine strains.

Authors:  Olga Borisova; Svetlana Yu Kombarova; Nelli S Zakharova; Marjolein van Gent; Vladimir A Aleshkin; Isabella Mazurova; Frits R Mooi
Journal:  Clin Vaccine Immunol       Date:  2007-01-03

8.  Bordetella pertussis proteins dominating the major histocompatibility complex class II-presented epitope repertoire in human monocyte-derived dendritic cells.

Authors:  Rachel M Stenger; Hugo D Meiring; Betsy Kuipers; Martien Poelen; Jacqueline A M van Gaans-van den Brink; Claire J P Boog; Ad P J M de Jong; Cécile A C M van Els
Journal:  Clin Vaccine Immunol       Date:  2014-03-05

9.  Transition State Structure for the Hydrolysis of NAD Catalyzed by Diphtheria Toxin.

Authors:  Paul J Berti; Steven R Blanke; Vern L Schramm
Journal:  J Am Chem Soc       Date:  1997-12-17       Impact factor: 15.419

10.  Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data.

Authors:  H E de Melker; J F Schellekens; S E Neppelenbroek; F R Mooi; H C Rümke; M A Conyn-van Spaendonck
Journal:  Emerg Infect Dis       Date:  2000 Jul-Aug       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.